Monday, May 10, 2010

• Radient Pharmaceuticals Announces Dr. Afsaneh Motamed-Khorasani Joins RPC as Director of Oncology --- TUSTIN, CA
  Posted at 9:24 AM
  

  TUSTIN, CA -- (Marketwire) -- 05/10/10 -- US-based pharmaceutical company Radient Pharmaceuticals Corporation (RPC) (NYSE Amex: RPC) announced today the appointment of Dr. Afsaneh Motamed-Khorasani as Director of Oncology. Dr. Motamed-Khorasani will be responsible for medical affairs for RPC's Onko-Sure™ in vitro diagnostic (IVD) cancer test, including product research and development, collaboration with Mayo Clinic to advance development of RPC's next-generation Onko-Sure IVD cancer test, on-going clinical trial work, authorship and publication of scientific white papers, articles, abstracts ... read more